MedPath

Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions

Phase 4
Terminated
Conditions
Fibroid/Myoma (Uterus/Cervix)
Chocolate Cyst of Ovary
Endometriosis of the Cul-de-sac
Interventions
Procedure: full conditioning
Procedure: standard pneumoperitoneum
Registration Number
NCT01344486
Lead Sponsor
University Hospital, Gasthuisberg
Brief Summary

Full conditioning of the peritoneal cavity during laparoscopic surgery will decrease post-operative pain, inflammation and adhesion formation.

Full conditioning will decrease an inflammatory response of the peritoneum and decrease pain and adhesion formation.

Detailed Description

Randomized controlled trial (RCT) comparing carbon dioxide to full conditioning (addition of oxygen, nitrous oxide, humidification and temperature control, dexamethasone and Hyalobarrier gel) Women undergoing laparoscopy for endometriosis, myomectomy or adhesiolysis will be randomized to either group and will be compared for pain (VAS scores); inflammation (White blood cells, CRP) and adhesions scored by second look laparoscopy.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
22
Inclusion Criteria
  • women undergoing laparoscopic excision of deep endometriosis (stratum 1), excision of endometrioma's (stratum 2) or excision of uterine myoma's (stratum 3) since this is severe surgery, associated with severe postoperative adhesions and since for most of these women fertility is important and hence the second look laparoscopy can be beneficial.
  • Signed informed consent
Exclusion Criteria
  • women with a pre-existing condition increasing the risk of surgery such as clotting disorders, heart or lung impairment etc.-Any condition that might interfere with inflammatory parameters such as immunodeficiency, chronic inflammatory disease as Crohn's disease.
  • Pregnancy
  • Conditions associated with chronic pain as peripheral neuropathy, pathology of the vertebral column and osteo-articular disease. Conditions causing acute pain e.g. abdominal trauma
  • a known allergic reaction to Hyalobarrier Gel Endo®
  • A bowel lesion requiring a single or double layer suture. (given that for none of the anti-adhesion barriers safety has been proven following bowel lesions and suture)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Full conditioingfull conditioningIntervention by alteration of laparoscopic gas with addition of oxygen and nitrous oxide, regulation of humidification and temperature (32°C), injection of 5mg Dexamethasone and application of Hyalobarrier Gel Endo (Nordic Pharma) at the surgical wound
carbon dioxidestandard pneumoperitoneuminduction pneumoperitoneum with carbon dioxide 100%
Primary Outcome Measures
NameTimeMethod
adhesion formation after laparoscopic surgery2 weeks after primary surgery

second look laparoscopy to assess adhesions formed after initial surgery

Secondary Outcome Measures
NameTimeMethod
inflammationrecorded until 3 days after surgery

bloodsamples to test for C reactive protein and white blood cells

time to first flatus and stoolrecorded until 3 days after surgery

patients will be asked when first flatus and first stool appeared. (measured as hours after surgery)

Post-operative painrecorded until 3 days after surgery

pain assessed by VAS scores

Trial Locations

Locations (1)

UZ Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath